Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Stock Report

| More

Strong Financial Performance Propels Growth for Lincoln Pharmaceuticals Ltd in Q3 FY24

Posted On: 2024-02-08 22:46:09 (Time Zone: IST)

Lincoln Pharmaceuticals Ltd, a prominent player in the healthcare sector, has unveiled its financial results for the third quarter of the fiscal year 2023-24, showcasing impressive growth and resilience amidst challenging market conditions.

Robust Financial Highlights:

Total Income from Operations: The company reported a total income from operations of ?157.47 crores in Q3 FY24, marking a significant increase of 12.38% compared to the same period last year. The cumulative total income for the nine months of FY24 stood at ?465.46 crores, reflecting a commendable growth rate of 11.78% over the previous year.

EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) surged to ?40.67 crores in Q3 FY24, registering a robust year-on-year growth of 22.91%. The cumulative EBITDA for the nine months of FY24 reached ?108.93 crores, representing a notable increase of 19.57% compared to the corresponding period in FY23.

Profitability: The company's profit before tax (PBT) for Q3 FY24 stood at ?37.71 crores, reflecting a substantial year-on-year growth of 23.56%. Similarly, the net profit after tax (PAT) witnessed a remarkable surge, reaching ?28.04 crores, representing a growth of 29.75% compared to Q3 FY23. The earnings per share (EPS) also exhibited a strong growth trajectory, increasing by 29.75% to ?14.00.
Lincoln Pharmaceuticals Ltd's strong financial performance in Q3 FY24 underscores its resilience and ability to navigate through market challenges effectively. The impressive growth in total income from operations, EBITDA, and profitability metrics reflects the company's robust business model, strategic initiatives, and operational efficiency.

The company's focus on innovation, customer-centric approach, and prudent financial management has positioned it well to capitalize on emerging opportunities and drive sustainable growth in the long term. Additionally, Lincoln Pharmaceuticals Ltd's commitment to quality, reliability, and excellence remains unwavering, contributing to its continued success and market leadership.

Looking ahead, Lincoln Pharmaceuticals Ltd is poised to leverage its strengths and capitalize on favorable market dynamics to further enhance shareholder value and deliver superior returns. With a positive outlook for the industry and a strong financial foundation, the company is well-equipped to navigate through uncertainties and emerge as a key player in the healthcare sector.

Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Limited, said, "We are pleased to announce that the company has sustained strong growth across all business segments in Q3 and nine months of FY24, maintaining a net debt-free status. We anticipate even stronger growth in the future through upcoming product launches in domestic and export markets, improved operational efficiency, and the introduction of higher-margin products. With our steadfast growth strategies, expansion plans for products and markets, and focus on operational efficiency, we are targeting revenue of Rs. 750 crore in FY26."

The company has completed the expansion of its Cephalosporin plant in Mehsana, Gujarat, and has commenced commercial production, with sales initiated in domestic markets. Plans are underway to register the product for export to multiple countries, with anticipated sales of approximately Rs. 150 crore over the next 3 years.

The company currently exports to over 60 countries across East & West Africa, Central, North & Latin America, and Southeast Asia. Recently, exports to Canada have commenced. With approvals from TGA - Australia and EU GMP, the company anticipates expanding its network to over 90 countries, further enhancing its global presence.

Shares of Lincoln Pharmaceuticals Limited was last trading in BSE at Rs. 661.45 as compared to the previous close of Rs. 671.50. The total number of shares traded during the day was 25528 in over 1142 trades.

The stock hit an intraday high of Rs. 702.05 and intraday low of 649.05. The net turnover during the day was Rs. 17651789.00.

Click here to send ur comments or to

Other Headlines:

The South Indian Bank Ltd approves 1:4 rights issue at Rs. 22 per share

Club Mahindra partners with The Marmara ?i?li Resort in Turkey to provide its members with holiday options in Istanbul

PVP Ventures Ltd announces a Joint Development with Brigade Enterprises Ltd

Mangal Credit and Fincorp Ltd approves preferential issue

Vikas Lifecare Ltd's Subsidiary PME Entertainment Presents Two Spectacular Events in Dubai

Genpharmasec Limited allots 27,68,59,850 Rights Equity Shares

Dow Jones and Infosys Introduce Upgraded Preference Center for Wall Street Journal Subscribers

Union Bank of India sanctions OTS of Kridhan Infra Ltd

Ceinsys Tech Ltd receives order

Ashiana Housing Ltd launches Phase 1 of Ashiana Nitara

Apollo Micro Systems Ltd receives term loan sanction from SBI

Brigade Group to expand its Residential and Hospitality Portfolios in Chennai

LTIMindtree and Eurolife FFH Sign MoU to Setup Gen Al and Digital Hubs in Europe and India

63 moons unveils disruptive technology in Cybersecurity

Airtel strengthens its retail footprint in Vijaywada

TVS Eurogrip exhibits prominent agri related products at Krishi Darshan Expo in Haryana

Infosys Foundation and the Centre for Cellular and Molecular Platforms to Strengthen Maternity Care in Karnataka

Mafatlal Industries Limited's Annual Report wins Platinum Award

Ambuja Cements Proposes Setting up a 4 MTPA Cement Grinding Unit in Godda, Jharkhand

Airtel adds 39 new stores in Chennai, doubles its retail store presence

PennWhite Limited, UK forms subsidiary in India

UltraTech Cement Limited commissions 1.8 MTPA brownfield cement capacity at Kotputli, Rajasthan

HFCL to Expand Presence in Europe with setting up of Optical Fiber Cable Plant in Poland

Vipul Organics participates in PAINTINDIA, the largest paint exhibition of the country

Ericsson and Airtel successfully demonstrate 5G FWA functionality on mmWave

Co-op Expands Partnership with TCS with a Cloud-First Strategy to Support its Business Growth and Sustainability Roadmap

Popeyes India brings a dash of Louisiana to the heart of Delhi with its first store in Chandni Chowk

Patel Engineering Ltd JV declared L1 for irrigation project worth Rs. 525.36 crores

Cosmo First wins two prestigious awards

Airtel adds 4 new stores, doubles its retail store presence in Bhubaneshwar

Zen Technologies Ltd receives order worth Rs. 93 crores

Lumos selects STL as a partner to build transformative 100% fiber optic internet infrastructure in the US

BluSmart inks multi-year PPA with Tata Power arm

Zaggle Prepaid Ocean Services Ltd enters into agreement with Arcadis Consulting

CarLelo unveils new brand identity at Women Premier League 2024

Airtel doubles its retail store presence in Amritsar, adds 3 new stores

G R Infraprojects Ltd to sell 7 subsidiaries to Bharat Highways InvIT

Bright Outdoor Media Ltd gets BSE nod for preferential issue

Valiant and CXR cooperation for Cyber Security solutions in France and neighboring European countries

Kilburn Engineering Ltd expands portfolio with acquisition of M.E Energy

Seedlings India Pvt Ltd gets patent

Garment Mantra Lifestyle Ltd to set up new wholesale hub in Surat

Satin Creditcare forays into Telangana and Andhra Pradesh

Revolt Motors accelerates presence with 15 New Dealerships Across India

Wipro and Intel Foundry announce new collaboration to Advance Chip Design and Development

Godrej Industries Limited - Chemicals features in The CDP Climate Change Leadership Index

ESAF Small Finance Bank gets ISO certification for operations

ABB India reports net profit of Rs. 338.66 crores in Q4 CY2023

IMplus Capitals Ltd consolidated Q3 FY24 net profit at Rs. 41.86 crores

GR Tarakote Sanjichhat Ropeway Pvt Ltd signs concession agreement with Shri Mata Vaishno Devi Shrine Board

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020